Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
-0.78% $0.396
America/New_York / 27 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 20.11 mill |
EPS: | -0.770 |
P/E: | -0.510 |
Earnings Date: | N/A |
SharesOutstanding: | 50.81 mill |
Avg Daily Volume: | 0.0741 mill |
RATING 2024-03-27 |
---|
B- |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Neutral | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | ||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.510 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.510 | industry: PE 222.16 |
DISCOUNTED CASH FLOW VALUE |
---|
$0.313 (-20.95%) $-0.0829 |
Date: 2024-03-28 |
Expected Trading Range (DAY) |
---|
$ 0.348 - 0.444 ( +/- 12.13%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Forte Nan Kirsten | Buy | 20 000 | Stock option (right to buy) |
2024-01-02 | Fairbairn Emily | Buy | 25 000 | Stock option (right to buy) |
2023-11-08 | Fairbairn Emily | Buy | 5 000 | Stock option (right to buy) |
2024-01-02 | Cullinan Brian | Buy | 20 000 | Stock option (right to buy) |
2024-01-02 | Caballero Ruben | Buy | 20 000 | Stock option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 95 transactions |
Buy: 3 544 000 | Sell: 2 979 608 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $0.396 (-0.78% ) |
Volume | 0.0144 mill |
Avg. Vol. | 0.0741 mill |
% of Avg. Vol | 19.41 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.